StonvexLoading…
StonvexStonvexStonvexCore line items from HDSN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $246.61M | $237.12M | $289.02M | $325.23M |
Operating Income | $18.56M | $29.30M | $78.17M | $131.51M |
Net Income | $16.67M | $24.39M | $52.25M | $103.80M |
EPS (Diluted) | $0.37 | $0.52 | $1.10 | $2.20 |
Total Assets | $318.65M | $302.65M | $296.67M | $272.49M |
Total Liabilities | $75.26M | $56.80M | $67.90M | $97.62M |
Cash & Equivalents | $39.46M | $70.13M | $12.45M | $5.29M |
Free Cash Flow OCF − CapEx | $-8.21M | $86.51M | $54.97M | $59.16M |
Shares Outstanding | 41.65M | 44.28M | 45.50M | 45.29M |